Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with ...

Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...

New research suggests semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, could help people reduce their alcohol consumption.

Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...

A new study will investigate whether prenatal antibiotic use impairs breast milk immune function and disrupts neonatal gut ...

Insights from Prothena's Q4 2024 call highlight 2025 milestones: pivotal trial results for birtamimab & Alzheimer's programs.

Obesity significantly reduced the effectiveness of febuxostat-based urate-lowering therapy among men with gout, a recent ...

During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...

Candel Therapeutics' lead candidate CAN-2409 shows promising results in several indications. Find out why I rate CADL stock ...

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb ...

If validated prospectively, the findings could be ‘transformative’ for patients with no current medical options.

Oxford Drug Design has been awarded £1m in funding to progress its uUTI (uncomplicated urinary tract infection) antibacterial programme, as announced by PACE (Pathways to Antimicrobial Clinical ...